content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

Histogenics Corporation (HSGX)

1.95
0.03
(1.56%)
Sep 11, 4:00PM EDT
content_middle

Histogenics (HSGX) is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. HSGX's regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bio-adhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics' 1st investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.

Previous Close: 
1.92
Open: 
1.91
Bid: 
1.75
Ask: 
4.00
1yr Target Price: 
6.00
Day's Range: 
1.86 - 1.98
52wk Range: 
1.45 - 4.06
Volume: 
114011
Average Daily Volume: 
60529
Market Capitalization: 
43.86M
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
22490000M
content_right